CN Patent

CN108675998B — 一种结晶性氨基甲酸甲酯类化合物

Assigned to Beijing Kainger Collar Biotechnology Co., Ltd. · Expires 2019-08-13 · 7y expired

What this patent protects

本发明涉及一种结晶性氨基甲酸甲酯类化合物,即:N‑[(2S)‑1‑[(2S)‑2‑{4‑[7‑(4‑{2‑[(2S)‑1‑[(2S)‑2‑[(甲氧基羰基)氨基]‑3‑甲基丁酰基]吡咯烷‑2‑基]‑1H‑咪唑‑4‑基}苯基)‑2H‑1,3‑苯并二恶茂‑4‑基]‑1H‑咪唑‑2‑基}吡咯烷‑1‑基]‑3‑甲基‑1‑氧代丁烷‑2‑基]氨基甲酸甲酯二盐酸盐的晶型,以及包含所述晶型的药物组合物,和使用该晶型在治疗丙型肝炎病毒药物中的运用。

USPTO Abstract

本发明涉及一种结晶性氨基甲酸甲酯类化合物,即:N‑[(2S)‑1‑[(2S)‑2‑{4‑[7‑(4‑{2‑[(2S)‑1‑[(2S)‑2‑[(甲氧基羰基)氨基]‑3‑甲基丁酰基]吡咯烷‑2‑基]‑1H‑咪唑‑4‑基}苯基)‑2H‑1,3‑苯并二恶茂‑4‑基]‑1H‑咪唑‑2‑基}吡咯烷‑1‑基]‑3‑甲基‑1‑氧代丁烷‑2‑基]氨基甲酸甲酯二盐酸盐的晶型,以及包含所述晶型的药物组合物,和使用该晶型在治疗丙型肝炎病毒药物中的运用。

Drugs covered by this patent

Patent Metadata

Patent number
CN108675998B
Jurisdiction
CN
Classification
Expires
2019-08-13
Drug substance claim
No
Drug product claim
No
Assignee
Beijing Kainger Collar Biotechnology Co., Ltd.
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.